TARA — Protara Therapeutics, Inc.

TARAProtara Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · protaratx.com

4.660USD-5.28%Mkt Cap: 268.38M USDP/E: —Last update: 2026-05-26

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigatio…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap268.38M USD

Enterprise Value146.61M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-57.44M USD

Revenue/Share—

Last Price4.660 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees46

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS74365U1079

Valuation

P/E (Trailing)—

P/E (Forward)-3.24

PEG—

EV/EBITDA-2.10

EV/Revenue—

P/S—

P/B1.36

EPS (TTM)-1.36

EPS (Forward)-1.53

52W Range

2.77037% of range7.820

52W High7.820 USD

52W Low2.770 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-29.24%

ROA-27.42%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-56.37M USD

CapEx (TTM)94.00K USD

FCF Margin—

FCF Yield-14.66%

Net Debt-132.73M USD

Net Debt/EBITDA1.90

Balance Sheet

Debt/Equity0.02

Current Ratio15.69

Quick Ratio15.39

Book Value/Sh3.665 USD

Cash/Share2.416 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateJan 10, 2020

Splits

Last Split1:40

Split DateJan 10, 2020

Analyst Consensus

Rating1.3 (Strong Buy)

Target (Mean)26.57 USD

Target Range24.00 USD – 30.00 USD

# Analysts7

Ownership

Shares Out.56.20M

Float49.48M

Insiders2.39%

Institutions82.34%

Short Interest

Short Ratio10.5d

Short % Float11.09%

Short % Out.10.89%

Shares Short6.00M

Short (prev mo.)5.55M

Technical

SMA 505.177 (-10.0%)

SMA 2005.158 (-9.7%)

Beta1.52

S&P 52W Chg28.31%

Avg Vol (30d)730.96K

Avg Vol (10d)879.15K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—